3,430 Shares of SPDR S&P Biotech ETF $XBI Acquired by Fearless Solutions LLC dba Best Invest

Fearless Solutions LLC dba Best Invest bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,430 shares of the exchange traded fund’s stock, valued at approximately $541,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Enclave Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $237,000. Sivik Global Healthcare LLC increased its position in shares of SPDR S&P Biotech ETF by 20.0% during the third quarter. Sivik Global Healthcare LLC now owns 180,000 shares of the exchange traded fund’s stock valued at $28,382,000 after acquiring an additional 30,000 shares during the last quarter. Fragasso Financial Advisors Inc lifted its holdings in SPDR S&P Biotech ETF by 4.8% during the third quarter. Fragasso Financial Advisors Inc now owns 2,905 shares of the exchange traded fund’s stock worth $447,000 after acquiring an additional 133 shares during the period. Vertrix Wealth Management LLC lifted its holdings in SPDR S&P Biotech ETF by 5.0% during the third quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock worth $237,000 after acquiring an additional 71 shares during the period. Finally, Castleview Partners LLC lifted its holdings in SPDR S&P Biotech ETF by 61.9% during the third quarter. Castleview Partners LLC now owns 2,594 shares of the exchange traded fund’s stock worth $409,000 after acquiring an additional 992 shares during the period.

SPDR S&P Biotech ETF Trading Down 3.0%

XBI stock opened at $146.80 on Wednesday. The stock’s fifty day simple moving average is $158.57 and its two-hundred day simple moving average is $146.52. SPDR S&P Biotech ETF has a 1-year low of $103.43 and a 1-year high of $169.89. The stock has a market cap of $9.84 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.